Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine.
The upregulation of (C-X-C motif) receptor 3 (CXCR3) and its ligand (C-X-C motif) ligand (CXCL)10 (CXCL10) has been documented in many autoimmune disorders. Many studies have suggested that the CXCL10/CXCR3 axis plays a critical role in the autoimmune process and in β-cell destruction in Type 1 Diabetes (T1D). Serum CXCL10 level "Th1 chemokine" is high in T1D patients, and this suggests that CXCL10 may be a candidate for a predictive marker of T1D. Furthermore, serum CXCL10 levels measurement may be useful to assess the pathophysiology of the disease course in T1D. Blocking of the CXCL10 chemokine expression in newly onset of diabetes seems to be a possible approach for the therapy of T1D. Further studies are needed to investigate interactions between chemokines and cytokines in the pathogenesis of T1D.
Department of Clinical and Experimental Medicine, University of Pisa.
A
A
Corrado
Department of Clinical and Experimental Medicine, University of Pisa.
S M
SM
Ferrari
Department of Medical, Surgical, Maternal, Pediatric and Adult Sciences, University of Modena and Reggio Emilia, Italy.
C
C
Ferri
Department of Clinical and Experimental Medicine, University of Pisa.
E
E
Ferrannini
Department of Clinical and Experimental Medicine, University of Pisa.
A
A
Antonelli
Department of Clinical and Experimental Medicine, University of Pisa.
P
P
Fallahi
D001327:Autoimmune Diseases / Q000209:etiology; D054357:Chemokine CXCL10 / Q000502:physiology*; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology*; D004700:Endocrine System Diseases / Q000209:etiology; D006801:Humans
D054357:Chemokine CXCL10